How can America's healthcare system be transformed to provide consistently higher-quality and lower-cost care? Nothing else in healthcare matters more. Prescription for the Future identifies some standout medical organizations that have achieved higher-quality, more patient-focused, and lower-cost care, and from their examples distills twelve transformational practices that could transform the entire healthcare sector. Ezekiel J. Emanuel looks at individual physician practices and organizations who are already successfully driving change, and the specific practices they have instituted. They are not the titans everyone seems to know and assume to be the "best"; instead, Emanuel has chosen a select group--from small physician offices to large multi-specialty group practices, accountable care organizations, and even for-profit companies--that are genuinely transforming care. Prescription for the Future shines a bright diagnostic light on the state of American healthcare and provides invaluable insights for healthcare workers, investors, and patients. The book gives all of us the tools to recognize the places that will deliver high-quality, effective care when we need it.
This report, created by The Conference Board Quality Council, looks at the future role of quality throughout the enterprise.
This book was designed to be read in one evening, but the hyperlink references throughout the text may draw the reader to explore the topics online for days.
Encompassing Democrats and Republicans, along with legal, financial, and health policy experts, the essays here offer a fascinating and revealing insight into the political fight of a generation, its consequences for health care, politics, ...
Christensen applies the principles of disruptive innovation to the broken health care system with two pioneers in the field—Dr. Jerome Grossman and Dr. Jason Hwang. Together, they examine a range of symptoms and offer proven solutions.
Previously, Dr. Brennan served as executive vice president and chief medical officer of Aetna, Inc., from 2006 through 2008. From 2000 through 2006, he was president and chief executive officer of Brigham and Women's Physicians ...
Raises key questions about topics in the pharmaceutical industry, including how the risks of side effects are weighed, if privatization of that risk is prudent, and the high prices for drugs.